Jingyuan Mao

1.6k total citations · 1 hit paper
74 papers, 1.1k citations indexed

About

Jingyuan Mao is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Molecular Biology. According to data from OpenAlex, Jingyuan Mao has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 30 papers in Complementary and alternative medicine and 20 papers in Molecular Biology. Recurrent topics in Jingyuan Mao's work include Traditional Chinese Medicine Studies (21 papers), Traditional Chinese Medicine Analysis (14 papers) and Heart Rate Variability and Autonomic Control (8 papers). Jingyuan Mao is often cited by papers focused on Traditional Chinese Medicine Studies (21 papers), Traditional Chinese Medicine Analysis (14 papers) and Heart Rate Variability and Autonomic Control (8 papers). Jingyuan Mao collaborates with scholars based in China, United States and Netherlands. Jingyuan Mao's co-authors include Xianliang Wang, Jingyu Ni, Xiumei Gao, Guanwei Fan, Shan Gao, Lan Li, Yili Wang, Guanwei Fan, Meifeng Zhu and Yan Zhu and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Jingyuan Mao

71 papers receiving 1.1k citations

Hit Papers

Targeting MAPK-ERK/JNK pathway: A potential intervention ... 2024 2026 2024 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure
    2024 45 citations Zhihua Yang, Jingyuan Mao et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingyuan Mao China 17 488 284 248 173 139 74 1.1k
Dazhuo Shi China 19 431 0.9× 266 0.9× 274 1.1× 133 0.8× 82 0.6× 81 1.0k
Si Gao China 15 536 1.1× 163 0.6× 317 1.3× 104 0.6× 186 1.3× 23 1.1k
Lan Li China 13 388 0.8× 202 0.7× 164 0.7× 74 0.4× 121 0.9× 25 908
Qiyan Wang China 25 821 1.7× 484 1.7× 368 1.5× 162 0.9× 100 0.7× 53 1.5k
Xiaoyi Bao China 19 450 0.9× 108 0.4× 197 0.8× 96 0.6× 111 0.8× 26 911
Gaojun Wu China 19 680 1.4× 296 1.0× 118 0.5× 89 0.5× 249 1.8× 64 1.3k
Chunlai Zeng China 20 413 0.8× 344 1.2× 158 0.6× 58 0.3× 116 0.8× 48 1.1k
Yueh-Min Lin Taiwan 25 649 1.3× 137 0.5× 184 0.7× 102 0.6× 125 0.9× 62 1.4k
Hui-jun Yin China 18 397 0.8× 121 0.4× 272 1.1× 145 0.8× 91 0.7× 80 907
Huan He China 26 686 1.4× 288 1.0× 134 0.5× 67 0.4× 74 0.5× 65 1.5k

Countries citing papers authored by Jingyuan Mao

Since Specialization
Citations

This map shows the geographic impact of Jingyuan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyuan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyuan Mao more than expected).

Fields of papers citing papers by Jingyuan Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyuan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyuan Mao. The network helps show where Jingyuan Mao may publish in the future.

Co-authorship network of co-authors of Jingyuan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyuan Mao. A scholar is included among the top collaborators of Jingyuan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyuan Mao. Jingyuan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zhihua, et al.. (2025). Ferroptosis and pyroptosis: Mediating mechanisms of the cGAS/STING pathway and therapeutic strategies in heart failure. Ageing Research Reviews. 113. 102932–102932.
2.
Zhang, Zeyu, et al.. (2025). Natural products and ferroptosis: A novel approach for heart failure management. Phytomedicine. 142. 156783–156783. 3 indexed citations
3.
Zhang, Zeyu, Zhihua Yang, Shuai Wang, Xianliang Wang, & Jingyuan Mao. (2024). Overview of pyroptosis mechanism and in-depth analysis of cardiomyocyte pyroptosis mediated by NF-κB pathway in heart failure. Biomedicine & Pharmacotherapy. 179. 117367–117367. 9 indexed citations
4.
Zhang, Zeyu, et al.. (2024). Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure. Chinese Medicine. 19(1). 30–30. 5 indexed citations
5.
Yang, Zhihua, Yangxi Liu, Yu Liu, et al.. (2023). Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms. International Journal of Medical Sciences. 20(8). 1024–1037. 3 indexed citations
6.
Yang, Zhihua, Lin Wang, Yangxi Liu, et al.. (2023). Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms. Frontiers in Pharmacology. 14. 1154167–1154167. 7 indexed citations
7.
Wang, Shuai, Lin Wang, Linfeng Li, et al.. (2023). Effect of optimized new Shengmai powder on exercise tolerance in rats with heart failure by regulating the ubiquitin-proteasome signaling pathway. Frontiers in Cardiovascular Medicine. 10. 1168341–1168341. 7 indexed citations
8.
Wang, Shuai, et al.. (2023). Mechanism of new optimized Sheng-Mai-San Formula to regulate cardiomyocyte apoptosis through NMDAR pathway. Heliyon. 9(6). e16631–e16631. 7 indexed citations
9.
Zhou, Ruijuan, et al.. (2022). Efficacy and Safety of Yangyin Shuxin Decoction—a Chinese Herbal Medicine Formula For Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 2 indexed citations
10.
Gao, Shan, Lina Wang, Yu Zhang, et al.. (2020). Tanshinone IIA-loaded aligned microfibers facilitate stem cell recruitment and capillary formation by inducing M2 macrophage polarization. Applied Materials Today. 21. 100841–100841. 12 indexed citations
11.
12.
13.
Wang, Xianliang, et al.. (2016). [Assessment on Minnesota Living with Heart Failure Questionnaire in the Principle of Chinese Civilization and Traditional Medicine Characteristics].. PubMed. 36(9). 1072–1075. 1 indexed citations
14.
Cao, Shujuan, et al.. (2015). Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network. PLoS ONE. 10(12). e0144387–e0144387. 4 indexed citations
15.
16.
17.
Zhao, Zhiqiang & Jingyuan Mao. (2012). Currentsituation and prospect of the application of traditional Chinese medicine on treatment of chronic heart failure. Zhonghua zhongyiyao zazhi. 27(9). 2253–2257. 1 indexed citations
18.
Mao, Jingyuan, Hongcai Shang, Xianliang Wang, et al.. (2009). Study on the evaluation of the clinical effects of traditional chinese medicine in heart failure by complex intervention: protocol of SECETCM-HF. Trials. 10(1). 122–122. 12 indexed citations
19.
Mao, Jingyuan. (2008). Design idea of item of QOL scale with TCM characteristics to patients with CAD. Liaoning Zhongyiyao Daxue xuebao. 3 indexed citations
20.
Mao, Jingyuan, et al.. (2003). [Clinical study on effect of shengmai injection on serum concentration and pharmacokinetic parameters of digoxin in patients with congestive heart failure].. PubMed. 23(5). 347–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dazhuo Shi Breakdown of academic impact, for papers by Si Gao Breakdown of academic impact, for papers by Lan Li Breakdown of academic impact, for papers by Qiyan Wang Breakdown of academic impact, for papers by Xiaoyi Bao Breakdown of academic impact, for papers by Gaojun Wu Breakdown of academic impact, for papers by Chunlai Zeng Breakdown of academic impact, for papers by Yueh-Min Lin Breakdown of academic impact, for papers by Hui-jun Yin Breakdown of academic impact, for papers by Huan He
Rankless by CCL
2026